Higher expression of ATF6 and ATF6B predicts a better and poorer OS of the lung cancer patients, respectively, indicating a possible tumor suppressor-like activity of ATF6 and an oncogenic property of the ATF6B for lung carcinogenesis. The gene discussed is ATF6B; the disease is lung carcinoma.